Colorectal Cancer Blood Test Gets AdComm OK as Primary Screening Tool

While Shield, Guardant’s blood-based colorectal cancer screening test, got an overall thumbs-up from an FDA advisory committee, members stressed that it’s no substitute for colonoscopy.
Source: Drug Industry Daily